Fred Hutchinson Cancer Research Institute

Seattle, Washington 98109

We've found

1 trials

at this facility

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Seattle, WA

Use our guide to learn which trials are right for you!